Silencing AQP4 gene in the astrocytes through siRNA transfection by lipofectamine RNAiMAX

doi:10.3969/j.issn.0529-1356.2014.02.003

Acta Anatomica Sinica ›› 2014 ›› Issue (2) : 161-165. DOI: 10.3969/j.issn.0529-1356.2014.02.003

ZHANG Wei¹ XU Li-xin¹ YANG Shao-hua ^1,2 SHI Zhong-fang¹DONG Li-ping¹YUAN Fang^1*

Author information +

History +

Abstract

Objective To determine whether siRNA transfection with the help of Lipofectamine RNAiMAX can achieve AQP4 gene silencing in primary cultured astrocytes. Methods Primary cultured astrocytes from Wistar rat’s cerebral cortex were used in this study. Fluorescence microscope and Tecan microplate reader were used to examine whether Cy3-labeled siRNA can be transfected into astrocytes by lipofectamine RNAiMAX and the effects of different RNAiMAX concentration and siRNA concentration on the transfection efficiency. The silencing effect of AQP4 gene was detected by Real-time PCR. Results There were a lot of transfected cells under different transfection conditions as observed by fluoscence microscope. Tecan micropalte reader detection showed that the fluorescence intensity enhanced when siRNA and RNAiMAX concentrations increased. The level of AQP4 mRNA decreased more than 80 percent at 24 hours, 48 hours and 72 hours after 3ml/L RNAiMAX and 30nmol/L AQP4 siRNA or 6ml/L RNAiMAX and 60nmol/L AQP4 siRNA were used to transfection observed by Real-time PCR(n=6). Conclusion The fact that AQP4 mRNA significantly decreased after transfection indicates that siRNA can be successfully transfected into primary cultured astrocytes and silenced AQP4 gene by using Lipofectamine RNAiMAX.

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHANG Wei XU Li-xin YANG Shao-hua SHI Zhong-fang DONG Li-ping YUAN Fang*. Silencing AQP4 gene in the astrocytes through siRNA transfection by lipofectamine RNAiMAX[J]. Acta Anatomica Sinica. 2014(2): 161-165 https://doi.org/10.3969/j.issn.0529-1356.2014.02.003

References

［1］Kimelberg HK. Water homeostasis in the brain: basic concepts［J］. Neuroscience, 2004, 129(4):851-860.

［2］Papadopoulos MC, Verkman AS. Aquaporin-4 and brain edema［J］. Pediatr Nephrol, 2007, 22(6):778-784.

［3］Zhao M, Yang H, Jiang X,et al. Lipofectamine RNAiMAX: an efficient siRNA transfection reagent in human embryonic stem cells［J］. Mol Biotechnol, 2008, 40(1):19-26.

［4］McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue［J］. J Cell Biol, 1980, 85(3):890-902.

［5］Shi ZhF, Han M, Xu LX, et al. A scratch-wound model in cultured rat astrocytes［J］. Chinese Journal of Rehabilitation Theory and Practice, 2007, 13(12):1132-1133.(in Chinese)师忠芳，韩明，徐立新，等. 体外培养大鼠星形胶质细胞划伤模型［J］. 中国康复理论与实践，2007，13（12）：1132-1133.

［6］Qi LL, Fang SH, Shi WZ, et al. CysLT2 receptor-mediated AQP4 up-regulation is involved in ischemic-like injury through activation of ERK and p38 MAPK in rat astrocytes［J］. Life Sci, 2011, 88（1-2）:50-56.

［7］Zhang J, Hua ZC. Targeted gene silencing by small interfering RNA-based knock-down technology［J］. Curr Pharm Biotechnol, 2004, 5（1）:1-7.

［8］Cuccato G, Polynikis A, Siciliano V, et al. Modeling RNA interference in mammalian cells［J］. BMC Syst Biol, 2011, 5:19-30.

［9］Pathak A, Patnaik S, Gupta KC. Recent trends in non-viral vector-mediated gene delivery［J］. Biotechnol J, 2009, 4(11):1559-1572.

［10］Zhang S, Zhi D, Huang L. Lipid-based vectors for siRNA delivery［J］. J Drug Target, 2012, 20(9):724-735.

［11］Kamaci N, Emnacar T, Karakas N, et al. Selective silencing of DNA topoisomerase IIβ in human mesenchymal stem cells by siRNAs (small interfering RNAs)［J］. Cell Biol Int Rep, 2011, 18(1):e00010.

［12］Nabzdyk CS, Chun M, Pradhan L, et al. High throughput RNAi assay optimization using adherent cell cytometry［J］. J Transl Med, 2011, 9:48-56.